BioRender-Vorlage

A New Brain-Sparing Anti-Obesity Drug to Avoid Adverse Cardiovascular Effects

BioRender circle logo
Erstellt von 
Cirenia Arias Baldrich
  •  
BioRender Team
Diese Vorlage verwenden – Kostenlos
Für die Registrierung ist keine Kreditkarte erforderlich.

Diese Vorlage ist in BioRender vollständig bearbeitbar

  • Tauschen Sie Text, Formen und Icons einfach aus
  • Jedes Icon, jede Linie und jedes Label lässt sich umfärben und neu anordnen
  • Exportieren oder teilen für jeden Anwendungszweck
Scientist Avatars

Schließen Sie sich über 4 Millionen Wissenschaftlern an, die bereits publikationsreife Abbildungen erstellen

Description: This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication. Anti-obesity drugs in the amphetamine (AMPH) class act on the brain to reduce appetite and increase locomotion but produce adverse cardiovascular effects. These can be circumvented by PEGylation (PEGyAMPH). PEGyAMPH does not enter the brain and protects mice against obesity, increasing lipolysis and thermogenesis, coupled to heat dissipation, becoming a novel class of exclusively peripheral anti-obesity sympathofacilitators that are devoid of any cardiovascular and brain-related side effects.

Nicht die passende Vorlage gefunden? Entdecken Sie mehr.

Durchsuchen Sie Tausende von Vorlagen aus über 30 Bereichen der Biowissenschaften.

search icon
arrow-right

Versuchen Sie es mit einem Synonym oder registrieren Sie sich, um in der App eine Vorlage vorzuschlagen.

BioRender-Vorlagen-FAQs

What does the A New Brain-Sparing Anti-Obesity Drug to Avoid Adverse Cardiovascular Effects template show?

This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication. Anti-obesity drugs in the amphetamine (AMPH) class act on the brain to reduce appetite and increase locomotion but produce adverse cardiovascular effects. These can be circumvented by PEGylation (PEGyAMPH). PEGyAMPH does not enter the brain and protects mice against obesity, increasing lipolysis and thermogenesis, coupled to heat dissipation, becoming a novel class of exclusively peripheral anti-obesity sympathofacilitators that are devoid of any cardiovascular and brain-related side effects.

Is the A New Brain-Sparing Anti-Obesity Drug to Avoid Adverse Cardiovascular Effects template free to use?

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Can I edit or customize this template?

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Is this template accepted for use in journals, theses, or grant applications?

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

How do I cite BioRender if I use this template?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

What is A New Brain-Sparing Anti-Obesity Drug to Avoid Adverse Cardiovascular Effects used for / who typically uses this template?

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.

Bereit für den Start?

Erstellen Sie noch heute professionelle wissenschaftliche Abbildungen
antibody elements3D Phospholipid illustration